Maple Grove, MN – September 20, 2019 – UpsherSmith Laboratories, LLC (Upsher-Smith) today announced that executives from its parent company, Sawai Pharmaceutical Co., Ltd. (Sawai) including Sawai’s President, Mitsuo Sawai and General Manager of External Affairs, Yoshiomi Kunihiro, joined Minnesota Governor Tim Walz at the 51st Midwest U.S. Japan Association Conference.
The conference, which took place from September 7-10, 2019 in Tokyo, brought together leaders from Japan and the Midwest, including the governors from Illinois, Indiana, Nebraska, Ohio and Wisconsin to highlight their strong economic partnerships. Governor Walz traveled to Japan with representatives from the Minnesota Trade Office (MTO) at the Department of Employment and Economic Development (DEED). Minnesota is home to nearly 35 Japan-based companies.
“Minnesota is committed to unleashing economic opportunities across the globe,” said Governor Walz. “During this trip, I was able to state the case directly to international decisionmakers that Minnesota is a great place to do business and a company such as Upsher-Smith, that has achieved rapid growth and continues to expand as part of Japan-based Sawai, is a prime example.”
“It was a pleasure to meet with Governor Walz during his recent visit to Japan,” said Mitsuo Sawai, President, Sawai. “Minnesota is at the forefront of bioscience and as the parent company of Upsher-Smith, we are proud to be a part of a Company that has called this community home for 100 years.”
Upsher-Smith Laboratories, LLC is a trusted U.S. pharmaceutical company that strives to improve the health and lives of patients through an unwavering commitment to high-quality products and sustainable growth. Since 1919, it has brought generics and brands to a wide array of customers backed by an attentive level of service, strong industry relationships, and dedication to uninterrupted supply.
As Upsher-Smith celebrates its 100-year anniversary, the company enters a new ambitious era that has been accelerated by its 2017 acquisition by Sawai Pharmaceutical Co., Ltd. Upsher-Smith and Sawai plan to leverage each other for growth worldwide and embark on an exciting new chapter as they seek to deliver the best value for their stakeholders, and most importantly, Do More Good™ for the patients they serve. For more information, visit www.upsher-smith.com.
Founded in 1929, Sawai Pharmaceutical Co., Ltd. has grown into one of the leading generics companies in Japan. Guided by its corporate philosophy, “Always Putting Patients First,” Sawai markets more than 310 high-quality generic drugs with 760 strengths and reliably delivers them to patients throughout Japan. In 2017, Sawai acquired US-based Upsher-Smith Laboratories, LLC marking its first step in overseas expansion to become a globally recognized generic pharmaceutical company. For more information, visit: https://www.sawai.co.jp/en/.
Do More Good is a trademark of Upsher-Smith Laboratories, LLC.